Differentiation‐stage specific expression of oncoprotein 18 in human and rat prostatic adenocarcinoma
- 1 August 1995
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 27 (2) , 102-109
- https://doi.org/10.1002/pros.2990270207
Abstract
Oncoprotein 18 (Op18) is an intracellular phosphoprotein that has been shown to be overexpressed in a number of human malignancies. In the present report we have studied the pattern of Op18 expression in normal, hyperplastic, and malignant prostatic tissue as well as in rat prostatic tumor lines. One of the objectives of the present work was to establish whether the level of Op18 expression can be used as a prognostic marker in human prostatic adenocarcinoma. To that end, sections from normal, hyperplastic, and malignant human prostatic tissue were examined by immunohistochemistry for expression of Op18. In the normal and hyperplastic prostate, Op18 expression was observed in basal glandular epithelial cells, whereas the columnar luminal epithelial cells were not stained by the anti Op18 antibodies. In highly differentiated prostatic cancers occasional epithelial cells were stained, while in poorly differentiated tumors most of the epithelial cells contained Op18 immunoreactivity. The staining pattern was similar in the primary prostatic tumor and in the regional lymph node metastases. Most importantly, a limited survey of prostatic cancer patient samples (n = 40) showed a significant correlation between the fraction of Op18 immunoreactive cells and survival. Studies of a rat prostatic tumor model, showed that only a few cells were stained in the highly differentiated Dunning R3327PAP tumor, while most cells were stained in the anaplastic AT1 rat prostatic tumor. Interestingly, castration of rats resulted in an increased Op18 immunoreactivity, within 14 days, in the highly differentiated rat R3327PAP prostatic tumor. In conclusion, the level of Op18 expression seems to be related to cellular differentiation, histological grade, and survival in prostatic cancers. These findings show that Op18 immunoreactivity may be useful as a prognostic marker in prostatic cancer. In addition it may help in the differentiation between highly differentiated prostatic tumors and non-malignant conditions.Keywords
This publication has 28 references indexed in Scilit:
- Castration rapidly results in a major reduction in epithelial cell numbers in the rat prostate, but not in the highly differentiated dunning R3327 prostatic adenocarcinomaThe Prostate, 1993
- Cancer statistics, 1993CA: A Cancer Journal for Clinicians, 1993
- Differential expression of Op18 phosphoprotein during human thymocyte maturation.Journal of Clinical Investigation, 1992
- High expression of stathmin in multipotential teratocarcinoma and normal embryonic cells versus their early differentiated derivativesDifferentiation, 1992
- Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections.Journal of Histochemistry & Cytochemistry, 1991
- The prostate: An increasing medical problemThe Prostate, 1990
- Estrogen treatment combined with castration inhibits tumor growth more effectively than castration alone in the dunning R3327 rat prostatic adenocarcinomaThe Prostate, 1989
- Homology between the cDNAs Encoding Phosphoprotein p19 and SCG10 Reveals a Novel Mammalian Gene Family Preferentially Expressed in Developing BrainDNA, 1989
- Evidences for protein kinase C. Activation in T lymphocytes by stimulation of either the CD2 or CD3 antigensEuropean Journal of Immunology, 1989
- Intermediate filament expression and the progression of prostatic cancer as studied in the dunning R‐3327 rat prostatic carcinoma systemThe Prostate, 1989